| Identification | Back Directory | [Name]
6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside | [CAS]
1612191-89-5 | [Synonyms]
6-(Furan-2-yl)purine-beta-D-(3'-deoxy-3'-fluoro)riboside
6-(Furan-2-yl)purine-beta-D-(3’-deoxy-3’-fluoro)riboside
9H-Purine, 9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-(2-furanyl)-
(2R,3S,4S,5R)-4-Fluoro-2-(6-(furan-2-yl)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3-ol | [Molecular Formula]
C14H13FN4O4 | [MOL File]
1612191-89-5.mol | [Molecular Weight]
320.28 |
| Hazard Information | Back Directory | [Uses]
9-(3-Deoxy-3-fluoro-β-D-ribofuranosyl)-6-(furan-2-yl)purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|